ICD-10 Code for Leukocytosis: Complete Coding Guide
October 2, 2026
One of those lab findings that might imply a lot of various things is an elevated white blood cell count. It can occur during infection, after substantial physical stress, as a reaction to specific drugs, or in association with inflammatory and hematologic disorders. But often the root problem isn’t so obvious.
This uncertainty is one of the reasons why choosing the correct ICD-10 code for leukocytosis involves more than just looking for a high WBC result on a test report.
In most cases reported just as leukocytosis or high white blood cell count, unidentified, the usual ICD-10-CM code utilized is D72.829 – High white blood cell count, unspecified. The CMS coding tools have D72.829 for an indeterminate high WBC count . More specific codes are available when documentation identifies lymphocytosis , monocytosis , a leukemoid response , basophilia , bandemia or some other identified disorder .
That’s important distinction. Coding should be based on what the clinician really diagnosed, not just what was aberrant on the CBC.
This article gives an overview of the key leukocytosis ICD-10 codes, related to laboratory CPT codes, tips for documentation, typical coding errors, and practical considerations to help providers, clinics and hospitals submit cleaner claims.
What Is the ICD-10 Code for Leukocytosis?
The primary ICD-10 code for leukocytosis when no specific type has been documented is:
| ICD-10-CM Code | Description |
|---|---|
| D72.829 | Elevated white blood cell count, unspecified |
D72.829 includes documentation such as unspecified leukocytosis or an unspecified elevation of leukocytes.
This code is usually right when a provider has found a higher than white blood cell count but has not written down a more accurate white blood cell problem or made another clear diagnosis that explains the situation in a clear way.
The ICD-10-CM system also has more detailed D72.82-series codes. CMS also provides a list of specific codes for different types of white blood cell abnormalities. These include D72.820 for lymphocytosis D72.821 for monocytosis D72.823 for leukemoid reaction, D72.824 for basophilia and D72.828, for white blood cell counts.
The main point is to use the code that is supported by the medical record instead of automatically choosing D72.829.
Leukocytosis ICD-10 Codes at a Glance
The following codes may become relevant depending on what the provider documents.
| ICD-10-CM Code | Condition |
|---|---|
| D72.820 | Lymphocytosis (symptomatic) |
| D72.821 | Monocytosis (symptomatic) |
| D72.822 | Plasmacytosis |
| D72.823 | Leukemoid reaction |
| D72.824 | Basophilia |
| D72.825 | Bandemia |
| D72.828 | Other elevated white blood cell count |
| D72.829 | Elevated white blood cell count, unspecified |
| D72.89 | Other specified disorders of white blood cells |
| D72.9 | Disorder of white blood cells, unspecified |
These codes are not meant to replace each other. The right code should be chosen based on the providers written evaluation of guessing just because of lab results.
For instance if the doctor writes ” high white blood cell count cause not yet known ” D72.829 could be a good fit. If the doctor instead writes ” number of lymphocytes ” D72.820 would be a better choice, for the situation.
Understanding Leukocytosis Before Coding It
Leukocytosis means that the number of blood cells moving through the blood is higher than the normal range.
White blood cells help the body fight disease. They can increase in number when the body is dealing with infection. They can also increase when there is inflammation. They can become more numerous when there is an injury to tissue. They can increase when taking medicines. They can also increase when the body is, under stress. They can become more numerous when blood cells grow fast.
The finding itself does not tell the provider why the count is elevated.
A patient with an elevated WBC count may have a relatively straightforward infection. Another patient may have a medication-related elevation. A third may require additional evaluation for a hematologic disorder.
From a coding point of view this difference matters because leukocytosis is usually a sign or a second condition and not the main reason, for the patients health issue.
Once the doctor has found a diagnosis that explains the high count coding needs to follow the right ICD-10-CM rules and the condition that was written down.
When Should D72.829 Be Used?
D72.829 – Elevated white blood cell count, unspecified is most useful when leukocytosis has been clinically identified but its specific type has not been documented.
A typical note might read:
CBC demonstrates persistent leukocytosis. Etiology remains unclear. Repeat CBC with differential ordered.
In that situation, D72.829 can accurately represent what is known at the time of the encounter.
A patient may have a high WBC count on routine blood tests without an obvious cause. If the provider evaluates the finding and documents leukocytosis then D72.829 may be appropriate.
However the code D72.829 should not be assigned based on a lab result alone. Coding should always reflect the provider’s documentation.
D72.829 vs. D72.9: What Is the Difference?
These two codes are sometimes confused.
D72.829 specifically describes an elevated white blood cell count when the type of elevation has not been further specified.
D72.9, by comparison, means disorder of white blood cells, unspecified.
CMS lists D72.9 separately from D72.829 and describes it as an unspecified white blood cell disorder.
The difference can be summarized simply:
| Documentation | Potential Code |
|---|---|
| Leukocytosis | D72.829 |
| Elevated WBC, unspecified | D72.829 |
| Unspecified leukocyte disorder | D72.9 |
| Abnormal leukocyte differential, unspecified | D72.9 |
When documentation clearly identifies an elevated WBC count, D72.829 is normally more descriptive than the broader D72.9.
Specific Types of Elevated White Blood Cell Counts
Not every case of leukocytosis should remain undiagnosed. Testing for leukocytosis may include a blood count, with differential a peripheral smear, a thorough clinical examination and other diagnostic tests to find out which white cell type is increased.
Lymphocytosis – D72.820
D72.820 describes symptomatic lymphocytosis.
Lymphocytes are cells that’re part of the body’s defenses against illness. They play a role in the response and in making antibodies. When there are lymphocytes, than normal it can happen during infections when there is swelling or in some blood disorders.
If the doctor writes about lymphocytosis as part of an increase, in white blood cells use the more accurate code instead.
Monocytosis – D72.821
D72.821 represents symptomatic monocytosis.
Monocytes may increase with certain infections, inflammatory diseases, recovery from infections, or hematologic conditions.
The word monocytosis should be clearly supported in the documentation before this diagnosis is reported.
Plasmacytosis – D72.822
D72.822 is used for plasmacytosis.
This is a much more specific abnormality and should not be assigned simply because a patient’s total white blood cell count is high.
Leukemoid Reaction – D72.823
D72.823 represents a leukemoid reaction.
A leukemoid reaction means an increase in white blood cells that happens because of something else in the body. This increase can look like leukemia when doctors check the patient or do lab tests at first.
CMS lists D72.823 as one of the diagnoses that are linked to checking for problems with white blood cells.
The doctor needs to write down that a leukemoid reaction is present, before using this code.
Basophilia – D72.824
D72.824 describes basophilia.
Basophils are usually a part of the white blood cells in the body. If there are more basophils than usual for a time or a lot more, than normal it might mean more tests are needed.
It is better to say what the abnormal result is instead of just saying there is too many white blood cells.
Bandemia – D72.825
D72.825 represents bandemia.
Bandemia means there are immature neutrophils, called band cells in the blood than usual.
This can happen when the body is dealing with an infection or inflammation.. Having bandemia, by itself doesn’t tell us what the real problem is.
The ICD-10-CM tabular information distinguishes bandemia from a confirmed infection and from leukemia, reinforcing the importance of coding the established diagnosis when one is known.
Other Elevated White Blood Cell Count – D72.828
D72.828 is available when the elevated WBC abnormality is documented more specifically than simply “unspecified leukocytosis” but does not fit another listed category.
Documentation should support why this code is being selected.
Leukocytosis Is Not the Same as Leukemia
This is one of the most important distinctions in leukocytosis coding.
Leukocytosis is an elevated white blood cell count. Leukemia is a malignant hematologic disease.
A high white blood cell count can certainly happen with leukemia. Leukocytosis alone does not automatically mean leukemia.
The D72 white blood cell disorder category and the leukemia categories are separate in ICD‑10‑CM.
Leukemia is recorded in categories such, as C91‑C95 depending on the disease.
ICD‑10‑CM tabular guidance clearly separates leukemia from white cell abnormalities.
Providers should avoid documenting or coding leukemia until leukemia has actually been confirmed by the patient’s evaluation.
Likewise once a definitive hematologic diagnosis has been confirmed coding should accurately represent that condition of using an unspecified leukocytosis diagnosis as a substitute.
Leukocytosis Caused by Infection
Infection is one of the most common reasons a patient’s WBC count rises.
Consider a patient who presents with fever, productive cough, abnormal lung findings, elevated WBCs, and imaging confirming pneumonia.
The important diagnosis is not simply leukocytosis. The patient’s pneumonia is the clinically established condition driving the encounter.
Depending on the situation and the documentation leukocytosis. May not need to be reported on its own.
Providers must clearly write down how the findings, lab results and the final diagnosis connect. This helps make sure the claims reflect the care the patient received.
Just listing D72.829 without explaining a documented underlying condition can confuse the record. It makes the full picture harder to understand.
Leukocytosis Without a Confirmed Cause
The situation changes when the cause is not yet known.
Imagine that a patient’s CBC shows a WBC count that remains elevated across multiple visits. The patient has no obvious acute infection, and the physician begins additional investigation.
The note may state:
“Persistent leukocytosis. No clear infectious symptoms. Repeat CBC with differential and peripheral smear ordered. Hematology referral considered if elevation persists.”
Here, D72.829 can be useful because the documentation reflects an actual problem being evaluated rather than an incidental laboratory value.
This is where accurate documentation becomes especially important for medical necessity.
Common CPT Codes Related to Leukocytosis Evaluation
The ICD-10 code tells the payer why the patient was evaluated. CPT and HCPCS codes generally describe what service was performed.
Several laboratory services may be involved in evaluating an elevated white blood cell count.
| CPT Code | Common Use |
|---|---|
| 85025 | CBC with automated differential |
| 85027 | Automated CBC without automated differential |
| 85007 | Blood smear with manual differential WBC count |
| 85048 | Automated leukocyte count |
| 36415 | Collection of venous blood by venipuncture |
| 88184 | Flow cytometry, first marker, technical component |
| 88185 | Flow cytometry, each additional marker |
| 88187-88189 | Flow cytometry interpretation based on marker count |
CMS describes 85025 as a complete blood count with automated differential and 85027 as an automated complete blood count.
These codes should not simply be added to every leukocytosis claim. The service must actually have been ordered, performed, medically necessary, and properly documented.
CBC With Differential: CPT 85025
A CBC with automated differential is often one of the first tests used when an elevated WBC count is being evaluated.
CPT 85025 includes an automated hemogram along with an automated differential WBC count.
The differential helps find out which kinds of blood cells are higher than normal. This can give the doctor more helpful information, than just the total count.
For instance the pattern might show neutrophils or mostly lymphocytes or maybe monocytes or eosinophils or another type of cell.
This extra information can change whether the doctor writes down leukocytosis or a more exact diagnosis.
Automated CBC: CPT 85027
CPT 85027 represents an automated CBC without the automated WBC differential included in 85025.
CMS materials recognize both 85025 and 85027 as automated CBC services, with the key difference being the differential component.
Providers and laboratories should report the test that was actually ordered and performed.
Manual Differential: CPT 85007
A manual WBC differential may occasionally be needed when automated findings warrant additional review.
However, billing combinations matter.
The CMS National Correct Coding Initiative guidance says that code 85025 should not be used often with code 85007 because 85025 already includes a differential. CMS also says that codes 85027 and 85007 can be used when the doctor specifically asks for an automated hemogram and a manual differential.
This is a good example of why accurate coding involves more than matching one diagnosis with one procedure.
The actual services ordered and performed must be considered together.
Venipuncture: CPT 36415
When an eligible venous specimen is collected, CPT 36415 may apply for routine venipuncture.
CMS identifies 36415 for collection of venous blood by venipuncture and instructs that routine venipuncture performed during the same encounter is generally reported as a single service rather than once for every attempted blood draw.
Individual payer rules should still be reviewed before billing.
When Flow Cytometry May Enter the Picture
Most patients with a mildly elevated WBC count do not automatically need flow cytometry.
However, persistent or unusual leukocytosis, abnormal cell populations, suspicious morphology, or concern for a hematolymphoid disorder may lead the physician or hematologist to order more advanced testing.
Common flow cytometry codes include:
88184 for the first marker,
88185 for each additional marker,
and 88187-88189 for interpretation, depending on the number of markers evaluated.
CMS states that 88184 and 88185 are used for the technical component of flow cytometric immunophenotyping and that interpretation is reported with 88187-88189. CMS also specifies that only one interpretation code should be reported for all flow cytometry performed on a specimen.
These tests require appropriate clinical justification. Leukocytosis alone does not automatically make extensive flow cytometry medically necessary.
Documentation Requirements for Leukocytosis
Strong documentation is one of the best ways to prevent ambiguity in coding.
A useful leukocytosis note should explain more than the fact that the patient’s WBC count is high.
Ideally, the medical record should identify:
the provider’s clinical assessment of the elevated count,
whether the leukocytosis is new, persistent, improving, or worsening,
relevant symptoms or absence of symptoms,
pertinent CBC and differential findings,
possible contributing conditions,
medications that may affect white blood cell levels,
whether an infection or inflammatory process is suspected,
additional testing being ordered,
and the follow-up plan.
For example:
“Repeat CBC continues to show leukocytosis. Patient remains afebrile and denies respiratory or urinary symptoms. No clear infectious source identified. CBC with differential and peripheral smear ordered. Will repeat laboratory testing and consider hematology evaluation if elevation persists.”
This documentation gives much more clinical meaning to D72.829 than a note that simply states “high WBC.”
Do Not Code Directly From the Lab Result Alone
One of the easiest coding mistakes to make is turning every abnormal laboratory result into a diagnosis.
A WBC count outside the laboratory reference range is a finding.
The physician’s assessment determines whether that finding represents clinically significant leukocytosis requiring evaluation or treatment.
The medical record should connect the laboratory abnormality with the provider’s assessment.
If an elevated WBC count appears on routine blood work but the physician never identifies or addresses leukocytosis, assigning D72.829 simply from the lab report may not accurately reflect the encounter.
This distinction becomes especially important during payer reviews.
Common Causes of Leukocytosis
Leukocytosis can appear in many clinical settings.
Potential causes include acute infections, inflammatory conditions, significant physiologic stress, corticosteroid use, tissue injury, smoking, allergic or immune responses, pregnancy-related physiologic changes, and hematologic disorders.
Some causes are temporary. Others require ongoing investigation.
The coder’s role is not to determine which disease caused the laboratory finding. The diagnosis should come from the treating provider’s clinical documentation.
That is why a statement such as “elevated WBC likely secondary to corticosteroid therapy” is far more useful than simply recording the laboratory value.
Common Leukocytosis Coding Mistakes
Using D72.829 When a More Specific Diagnosis Is Documented
If the note clearly states lymphocytosis, monocytosis, basophilia, bandemia, or leukemoid reaction, an available specific code should be considered instead of automatically reporting unspecified leukocytosis.
Confusing D72.829 With D72.9
D72.829 describes an unspecified elevated WBC count, while D72.9 represents an unspecified white blood cell disorder.
They describe different levels of clinical information.
Treating Leukocytosis as Leukemia
A high WBC level does not confirm leukemia.
A malignant diagnosis should never be inferred solely from an abnormal CBC.
Ignoring the Underlying Diagnosis
When an established disease explains the patient’s presentation, the claim should reflect the conditions documented and managed during the encounter according to applicable coding guidelines.
Reporting Tests Without Clear Medical Necessity
Repeated CBCs, manual differential testing, flow cytometry, or other advanced laboratory studies should be supported by the patient’s clinical circumstances and payer requirements.
Overcoding Laboratory Services
More testing codes do not automatically make a claim more complete.
CMS NCCI guidance, for example, limits certain combinations involving automated CBCs and manual differential testing.
Correct billing means reporting what was medically necessary and actually performed.
Example 1: Unexplained Leukocytosis
A 52-year-old patient undergoes routine laboratory testing. The WBC count is elevated on two separate CBCs.
The patient has no fever, cough, urinary symptoms, or other obvious signs of infection.
The physician documents:
“Persistent leukocytosis of unclear etiology. Repeat CBC with differential ordered.”
A reasonable diagnosis to consider from the documented information is:
D72.829 – Elevated white blood cell count, unspecified
The laboratory service may include CPT 85025 when a CBC with automated differential is ordered and performed.
Example 2: Documented Lymphocytosis
A patient has a high total WBC count with an elevated lymphocyte population.
After reviewing the CBC and differential, the physician documents:
“Persistent lymphocytosis. Repeat CBC and hematology evaluation planned.”
Because the provider documented a specific white blood cell abnormality, D72.820 – Lymphocytosis (symptomatic) may be more appropriate than D72.829.
Example 3: Leukocytosis During an Infection
A patient presents with fever, cough, shortness of breath, elevated WBC count, and imaging findings consistent with bacterial pneumonia.
The physician documents pneumonia and notes reactive leukocytosis.
The claim should represent the documented illness driving the encounter, along with any additional reportable conditions when appropriate.
The presence of an elevated WBC count should not distract from the confirmed underlying diagnosis.
Example 4: Persistent Abnormal WBC Requiring Further Evaluation
A patient has progressively increasing WBC counts over several months. Repeat testing shows unusual cell populations, and the physician refers the patient to hematology.
Further testing may include a CBC with differential, peripheral blood evaluation, or flow cytometry when medically indicated.
At the initial stage, D72.829 may represent unexplained leukocytosis if that is what is documented. Once the evaluation establishes a more specific diagnosis, future coding should reflect the confirmed condition.
Medical Necessity and Payer Considerations
A correct ICD-10 code does not automatically guarantee coverage.
Payers may evaluate whether the diagnosis reasonably supports the laboratory service, whether the frequency of testing is justified, whether prior authorization applies, and whether specific coverage policies are satisfied.
This becomes particularly important with more advanced hematology testing.
CMS publishes local coverage and billing guidance for services such as flow cytometry, and coverage can depend on the patient’s clinical findings and the applicable Medicare Administrative Contractor policy.
Commercial insurers may have their own rules.
Providers should therefore avoid assuming that one leukocytosis diagnosis will support every hematology-related procedure.
How Better Documentation Supports Cleaner Leukocytosis Claims
Small improvements in documentation can make a significant difference.
Instead of documenting:
“High WBC.”
Consider:
“Persistent leukocytosis identified on repeat CBC. No clear infectious source. CBC with differential ordered for further evaluation.”
Instead of:
“Abnormal labs.”
Consider:
“Elevated WBC with lymphocyte predominance. Persistent lymphocytosis being evaluated.”
The second version in each example communicates what the physician actually assessed and why additional care is being provided.
Clear documentation can also reduce back-and-forth requests for records when payers review medical necessity.
Leukocytosis Coding and Revenue Cycle Accuracy
Claims involving laboratory abnormalities often appear simple but can become complicated when diagnosis specificity, medical necessity, procedure coding, payer edits, and repeated testing overlap.
A claim may have the correct lab test but an unsupported diagnosis. Another may contain a correct diagnosis but incorrectly report overlapping laboratory services.
Practices working with Maryland Medical Billing can benefit from reviewing whether diagnosis selection, laboratory coding, payer requirements, and documentation consistently support one another before claims are submitted.
The objective should not be to add more codes. It should be to create a claim that accurately reflects what happened during the patient encounter.
ICD-10-CM 2027 Update Reminder
Providers should always verify codes against the ICD-10-CM code set applicable to the actual date of service.
CMS states that the FY 2027 ICD-10-CM files apply to patient encounters from October 1, 2026 through September 30, 2027.
Because ICD-10-CM codes and instructions may change between annual releases, relying indefinitely on an old coding list can create avoidable errors.
A current code reference, payer policy, and official ICD-10-CM guidelines should always take priority over older internal coding sheets.
Quick Reference: Choosing the Right Leukocytosis Code
If the physician simply documents leukocytosis or elevated WBC without a defined type, consider:
D72.829 – Elevated white blood cell count, unspecified
If the physician documents lymphocytosis, consider:
D72.820
For monocytosis:
D72.821
For plasmacytosis:
D72.822
For a documented leukemoid reaction:
D72.823
For basophilia:
D72.824
For bandemia:
D72.825
For another specifically documented elevated WBC condition that does not fit the listed categories:
D72.828
The final code should always follow the provider’s documented diagnosis and the ICD-10-CM instructions applicable to the encounter.
Final Thoughts
The most commonly used ICD-10 code for leukocytosis is D72.829 – Elevated white blood cell count, unspecified, but it should not become a default code for every abnormal WBC result.
Good coding starts with the clinical documentation.
If the physician identifies a specific type of white blood cell elevation, the corresponding more specific code may be appropriate. If an infection, inflammatory disease, hematologic malignancy, medication effect, or another definitive condition has been established, the medical record should clearly describe that clinical picture.
The same principle applies to laboratory billing. CBCs, differentials, venipuncture, manual blood smear testing, and advanced studies such as flow cytometry should reflect what was actually ordered and medically necessary.
A well-documented encounter makes the coding decision much easier and creates a clearer connection between the patient’s condition and the services provided. For practices dealing with recurring coding edits, laboratory denials, or documentation gaps, Maryland Medical Billing can help review the broader billing workflow so claims more accurately reflect the care recorded in the medical chart.
Frequently Asked Questions
What is the ICD-10 code for leukocytosis?
The commonly used code for unspecified leukocytosis is D72.829 – Elevated white blood cell count, unspecified. CMS lists this code for unspecified elevated leukocytes and leukocytosis.
Is D72.829 the same as D72.9?
No. D72.829 specifically identifies an elevated white blood cell count that is unspecified, while D72.9 represents an unspecified disorder of white blood cells.
Can D72.829 be used for an abnormal WBC result?
It should be supported by the provider’s documented assessment. An abnormal laboratory result alone should not automatically be turned into a diagnosis without appropriate clinical documentation.
What CPT code is commonly used for a CBC with differential?
CPT 85025 is commonly used for an automated complete blood count with automated differential WBC count. CMS distinguishes it from 85027, which represents an automated CBC without the automated differential.
Is leukocytosis the same as leukemia?
No. Leukocytosis means the white blood cell count is elevated. Leukemia is a malignant hematologic disease. An elevated WBC count by itself does not establish leukemia.
What code is used for lymphocytosis?
When symptomatic lymphocytosis is specifically documented, D72.820 may apply.
Can leukocytosis support flow cytometry?
Potentially, but coverage depends on the patient’s clinical situation, medical necessity, documentation, and payer policy. Persistent or abnormal cell populations may lead to more advanced evaluation, but an elevated WBC count by itself does not automatically justify flow cytometry.
